Literature DB >> 1059158

Synthesis of hemoglobin AIc in normal and diabetic mice: potential model of basement membrane thickening.

R J Koenig, A Cerami.   

Abstract

Adult diabetic mice (C57Bl/KsJ--db/db) have increased amounts of a minor hemoglobin in their peripheral blood compared to wild-type (+/+) mice. This increase is analogous to the 2-fold increase of a glycohemoglobin with similar chromatographic mobility (Hb AIc) seen in the blood of patients with diabetes mellitus. Although the exact chemical nature of human or mouse Hb AIc is unknown, both contain a sodium-borohydride-reducible linkage on the beta chain which is a presumed Schiff base between a sugar moiety and the protein. The db/db animals, which have normal amounts of mouse Hb AIc at weaning, show the increase approximately 4 weeks after the onset of the signs of diabetes. This rise is brought about by an increase in a circulating factor that determines directly or indirectly the synthesis of mouse Hb AIc as a post-synthetic modification of Hb A. Evidence for this was obtained by showing that the rate of synthesis of the modified Hb is linear for at least the first 50 days of the life of the red cell and that the rate of synthesis is dependent on the environment in which the cells circulate. Thus the rate of mouse Hb AIc synthesis in +/+ cells is greater when those cells circulate in a db/db host than when they circulate in a +/+ host. The nature of the humoral factor is unknown. If glycosylations of basement membrane proteins and hemoglobin proceed via a common mechanism, then the monitoring of Hb AIc could provide a useful model for studying the early events of basement membrane thickening.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1059158      PMCID: PMC433062          DOI: 10.1073/pnas.72.9.3687

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  13 in total

1.  Pancreatic Extracts in the Treatment of Diabetes Mellitus.

Authors:  F G Banting; C H Best; J B Collip; W R Campbell; A A Fletcher
Journal:  Can Med Assoc J       Date:  1922-03       Impact factor: 8.262

2.  Structure of hemoglobin AIc: nature of the N-terminal beta chain blocking group.

Authors:  R M Bookchin; P M Gallop
Journal:  Biochem Biophys Res Commun       Date:  1968-07-11       Impact factor: 3.575

3.  Separation of the alpha and beta-chains of human hemoglobin.

Authors:  J B Clegg; M A Naughton; D J Weatherall
Journal:  Nature       Date:  1968-07-06       Impact factor: 49.962

4.  Skeletal muscle capillaries in diabetics. A quantitative analysis.

Authors:  R Vracko
Journal:  Circulation       Date:  1970-02       Impact factor: 29.690

5.  Hemoglobin components in patients with diabetes mellitus.

Authors:  L A Trivelli; H M Ranney; H T Lai
Journal:  N Engl J Med       Date:  1971-02-18       Impact factor: 91.245

6.  Studies of an unusual hemoglobin in patients with diabetes mellitus.

Authors:  S Rahbar; O Blumenfeld; H M Ranney
Journal:  Biochem Biophys Res Commun       Date:  1969-08-22       Impact factor: 3.575

7.  A new N-terminal blocking group involving a Schiff base in hemoglobin AIc.

Authors:  W R Holmquist; W A Schroeder
Journal:  Biochemistry       Date:  1966-08       Impact factor: 3.162

8.  Studies in the diabetic mutant mouse. VI. Evolution of glomerular lesions and associated proteinuria.

Authors:  A A Like; R L Lavine; P L Poffenbarger; W L Chick
Journal:  Am J Pathol       Date:  1972-02       Impact factor: 4.307

9.  Human glomerular basement membrane: chemical alteration in diabetes mellitus.

Authors:  P G Beisswenger; R G Spiro
Journal:  Science       Date:  1970-05-01       Impact factor: 47.728

10.  Diabetes, a new mutation in the mouse.

Authors:  K P Hummel; M M Dickie; D L Coleman
Journal:  Science       Date:  1966-09-02       Impact factor: 47.728

View more
  30 in total

1.  [Clinical and biochemical studies on the significance and formation of hemoglobins AIc and AIa+b in diabetes mellitus].

Authors:  R Dolhofer; A Städele; O H Wieland
Journal:  Klin Wochenschr       Date:  1977-10-01

2.  A surprising journey in translational medicine.

Authors:  Anthony Cerami
Journal:  Mol Med       Date:  2014-12-16       Impact factor: 6.354

3.  HbA1 in assessment of metabolic control in diabetic BB/E rats.

Authors:  F J Tames; J D Baird; A J Bone
Journal:  Diabetologia       Date:  1990-05       Impact factor: 10.122

4.  The biosynthesis of human hemoglobin A1c. Slow glycosylation of hemoglobin in vivo.

Authors:  H F Bunn; D N Haney; S Kamin; K H Gabbay; P M Gallop
Journal:  J Clin Invest       Date:  1976-06       Impact factor: 14.808

Review 5.  Diabetes Mellitus and Obesity as Risk Factors for Pancreatic Cancer.

Authors:  Guido Eibl; Zobeida Cruz-Monserrate; Murray Korc; Maxim S Petrov; Mark O Goodarzi; William E Fisher; Aida Habtezion; Aurelia Lugea; Stephen J Pandol; Phil A Hart; Dana K Andersen
Journal:  J Acad Nutr Diet       Date:  2017-09-12       Impact factor: 4.910

Review 6.  Haemoglobin A1 and diabetes mellitus.

Authors:  G Gonen; A H Rubenstein
Journal:  Diabetologia       Date:  1978-07       Impact factor: 10.122

7.  How quickly can haemoglobin A1 increase?

Authors:  R D Leslie; D A Pyke; P N John; J M White
Journal:  Br Med J       Date:  1979-07-07

8.  HbA1c standardisation destination--global IFCC Standardisation. How, why, where and when--a tortuous pathway from kit manufacturers, via inter-laboratory lyophilized and whole blood comparisons to designated national comparison schemes.

Authors:  Ian Goodall
Journal:  Clin Biochem Rev       Date:  2005-02

9.  Red cell age-related changes of hemoglobins AIa+b and AIc in normal and diabetic subjects.

Authors:  J F Fitzgibbons; R D Koler; R T Jones
Journal:  J Clin Invest       Date:  1976-10       Impact factor: 14.808

10.  The role of ascorbic acid in senile cataract.

Authors:  K G Bensch; J E Fleming; W Lohmann
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.